Compare CYRX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYRX | SOPH |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | Switzerland |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 367.7M |
| IPO Year | 2008 | 2021 |
| Metric | CYRX | SOPH |
|---|---|---|
| Price | $10.55 | $4.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $13.31 | $7.50 |
| AVG Volume (30 Days) | ★ 409.4K | 88.6K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | $23.09 |
| Revenue Next Year | $8.45 | $19.57 |
| P/E Ratio | $7.28 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.31 | $2.59 |
| 52 Week High | $11.45 | $5.70 |
| Indicator | CYRX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 68.70 | 46.53 |
| Support Level | $9.18 | $4.55 |
| Resistance Level | $11.33 | $4.86 |
| Average True Range (ATR) | 0.41 | 0.27 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 82.83 | 33.33 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.